Nano-drug Clinical Trials: Informed Consent and Risk Management Through Blockchain

Drug bearing nano-shells that can be utilized for targeted drug delivery have been shown to enhance the therapeutic index by increasing dug concentration in diseased tissue and reducing toxicity normal tissue. The controllability of shell size provides predictability measure amount payload per which improves administration dose. FDA approved different formulations clinical use metastatic recurrent breast cancer, among other diseases. At moment, some these are subject international trials. Informed consent is legally mandated administering nano-shells. risks new formulations, as with all technologies, not well known continue a intensive research, thus exacerbating existing informed legal issues, issues. This short essay focuses on proposing framework mitigate liabilities formulation nano-enabled carriers particularly when uncertainties benefits damages fully known.